The 3rd. Annual SELECTBIO Circulating Biomarkers World Congress 2016 brings together academic researchers as well as industry participants to present and discuss the most up-to-date research and commercial activities in the translation of various circulating biomarker classes towards the clinic.
This Congress discusses Nucleic Acid-based Biomarkers, Protein-based Biomarkers, Extracellular Vesicle (EV)-based Biomarkers (contained within exosomes and microvesicles), and Circulating Tumor Cell (CTC)-based Biomarkers.
One of the conference tracks focuses on Companion Diagnostics as the fields of Circulating Biomarkers and Companion Diagnostics development are converging and the various classes of Circulating Biomarkers may be developed into Companion Diagnostics enabling Biofluid/Liquid Biopsies in the future.
A co-located exhibit hall features companies developing technologies and products for the complete workflow from sample isolation, preparation, through data analysis.
Conference delegates receive access to all three co-located conference tracks, can mix-and-match presentations from all three tracks thereby maximizing the conference experience, and can network with delegates from the various co-located tracks and exhibition.